Walgreens Boots Alliance Goes Private After Sycamore Partners Acquisition
PorAinvest
jueves, 28 de agosto de 2025, 12:21 pm ET1 min de lectura
WBA--
Under the terms of the deal, Sycamore Partners will acquire WBA from Stefano Pessina and his holding company, Alliance Santé Participations S.A. The acquisition includes a cash consideration of $11.45 per share and a non-transferable right to receive up to $3.00 in cash per share from the future monetization of WBA's debt and equity interests in VillageMD [1]. This transaction represents a premium of up to 63% on WBA's closing share price of $8.85 on December 9, 2024 [1].
The acquisition has led to significant changes within the company. WBA's various segments, including VillageMD, The Boots Group, Shields Health Solutions, CareCentrix, and Walgreens, will now operate as independent businesses. Sycamore has appointed Mike Motz, former CEO of Staples U.S. Retail, as the new CEO of Walgreens. Motz will oversee the company's transition to a private entity and focus on its core pharmacy and retail platform [2].
Stefano Pessina, the long-time chairman of WBA, will remain involved in the company's operations after reinvesting his family's shares. He will continue to support the company alongside Sycamore Partners [2].
The acquisition is part of Sycamore Partners' strategy to invest in and grow private companies. The deal was facilitated by a consortium of financial advisors, including UBS Investment Bank, Goldman Sachs, J.P. Morgan, Citi, and Wells Fargo, as well as legal and regulatory counsel [1][2].
References:
[1] https://www.marketscreener.com/news/sycamore-partners-management-l-p-completed-the-acquisition-of-walgreens-boots-alliance-inc-from-s-ce7c50dcd98ff524
[2] https://chainstoreage.com/walgreens-names-new-ceo-company-goes-private
Walgreens Boots Alliance (WBA) has been acquired by Sycamore Partners and is now a private company. The deal marks the end of WBA's 124-year history as a publicly traded company on the Nasdaq. The pharmacy chain's various segments will now operate as independent businesses, and Staples CEO Mike Motz will take over as CEO. Longtime chairman Stefano Pessina will remain involved after reinvesting his family's shares.
Walgreens Boots Alliance (WBA), a global pharmacy chain, has been acquired by Sycamore Partners, marking the end of its 124-year history as a publicly traded company on the Nasdaq. The acquisition, completed on August 28, 2025, values WBA at approximately $10 billion [2].Under the terms of the deal, Sycamore Partners will acquire WBA from Stefano Pessina and his holding company, Alliance Santé Participations S.A. The acquisition includes a cash consideration of $11.45 per share and a non-transferable right to receive up to $3.00 in cash per share from the future monetization of WBA's debt and equity interests in VillageMD [1]. This transaction represents a premium of up to 63% on WBA's closing share price of $8.85 on December 9, 2024 [1].
The acquisition has led to significant changes within the company. WBA's various segments, including VillageMD, The Boots Group, Shields Health Solutions, CareCentrix, and Walgreens, will now operate as independent businesses. Sycamore has appointed Mike Motz, former CEO of Staples U.S. Retail, as the new CEO of Walgreens. Motz will oversee the company's transition to a private entity and focus on its core pharmacy and retail platform [2].
Stefano Pessina, the long-time chairman of WBA, will remain involved in the company's operations after reinvesting his family's shares. He will continue to support the company alongside Sycamore Partners [2].
The acquisition is part of Sycamore Partners' strategy to invest in and grow private companies. The deal was facilitated by a consortium of financial advisors, including UBS Investment Bank, Goldman Sachs, J.P. Morgan, Citi, and Wells Fargo, as well as legal and regulatory counsel [1][2].
References:
[1] https://www.marketscreener.com/news/sycamore-partners-management-l-p-completed-the-acquisition-of-walgreens-boots-alliance-inc-from-s-ce7c50dcd98ff524
[2] https://chainstoreage.com/walgreens-names-new-ceo-company-goes-private

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios